Liu Qian, Huang Xiaodong, Chen Xuesong, Zhang Jianghu, Wang Jingbo, Qu Yuan, Wang Kai, Wu Runye, Zhang Ye, Xiao Jianping, Yi Junlin, Luo Jingwei
Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
J Neurol Surg B Skull Base. 2022 Dec 30;85(1):28-37. doi: 10.1055/a-1980-8567. eCollection 2024 Feb.
Our objective was to compare the long-term outcomes of endoscopic resection versus open surgery in combination with radiotherapy for locally advanced sinonasal malignancies (SNMs). Data for continuous patients with sinonasal squamous cell carcinoma and adenocarcinoma who received surgery (endoscopic or open surgery) combined with radiotherapy in our center between January 1999 and December 2016 were retrospectively reviewed. A 1:1 matching with propensity scores was performed. Overall survival (OS), progression-free survival (PFS), and local recurrence rate (LRR) were evaluated. We identified 267 eligible patients, 90 of whom were included after matching: 45 patients in the endoscopy group and 45 in the open group. The median follow-up time was 87 months. In the endoscopic group, 84.4% of patients received intensity-modulated radiotherapy (IMRT), with a mean gross tumor volume (GTV) dose of 68.28 Gy; in the open surgery group, 64.4% of patients received IMRT, with a mean GTV dose of 64 Gy. The 5-year OS, PFS, and LRR were 69.9, 58.6, and 24.5% in the endoscopic group and 64.6, 54.4, and 31.8% in the open surgery group, respectively. Multivariable regression analysis revealed that the surgical approach was not associated with lower OS, PFS, or LRR. The overall postoperative complications were 13% in the endoscopic group, while 21.7% in the open group. For patients with locally advanced SNMs, minimally invasive endoscopic resection, in combination with a higher radiation dose and new radiation techniques such as IMRT, yields survival outcomes similar to those of open surgery in combination with radiotherapy.
我们的目的是比较内镜切除术与开放手术联合放疗治疗局部晚期鼻窦恶性肿瘤(SNM)的长期疗效。回顾性分析了1999年1月至2016年12月期间在我们中心接受手术(内镜或开放手术)联合放疗的连续性鼻窦鳞状细胞癌和腺癌患者的数据。采用倾向评分进行1:1匹配。评估总生存期(OS)、无进展生存期(PFS)和局部复发率(LRR)。我们确定了267例符合条件的患者,其中90例在匹配后纳入:内镜组45例,开放组45例。中位随访时间为87个月。在内镜组中,84.4%的患者接受调强放疗(IMRT),平均肿瘤总体积(GTV)剂量为68.28 Gy;在开放手术组中,64.4%的患者接受IMRT,平均GTV剂量为64 Gy。内镜组的5年OS、PFS和LRR分别为69.9%、58.6%和24.5%,开放手术组分别为64.6%、54.4%和31.8%。多变量回归分析显示,手术方式与较低的OS、PFS或LRR无关。内镜组术后总体并发症发生率为13%,而开放组为21.7%。对于局部晚期SNM患者,微创内镜切除术联合更高的放疗剂量和IMRT等新放疗技术,其生存结果与开放手术联合放疗相似。